[HTML][HTML] Dissecting FGF signalling to target cellular crosstalk in pancreatic cancer
EP Carter, AS Coetzee, E Tomas Bort, Q Wang… - Cells, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
EP Carter, AS Coetzee, ET Bort, Q Wang… - Cells, 2021 - researchportal.bath.ac.uk
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer.
EP Carter, AS Coetzee, E Tomas Bort… - Cells (2073 …, 2021 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
[PDF][PDF] Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer. Cells 2021, 10, 847
EP Carter, AS Coetzee, E Tomas Bort, Q Wang… - 2021 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
[PDF][PDF] Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
EP Carter, AS Coetzee, E Tomas Bort, Q Wang… - CELLS, 2021 - qmro.qmul.ac.uk
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
ET Bort, Q Wang, HM Kocher, RP Grose - Cells, 2021 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer.
EP Carter, AS Coetzee, T Bort, Q Wang, HM Kocher… - Cells, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
EP Carter, AS Coetzee, ET Bort, Q Wang… - Cells, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
[HTML][HTML] Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
EP Carter, AS Coetzee, ET Bort, Q Wang, HM Kocher… - Cells, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer.
EP Carter, AS Coetzee, T Bort, Q Wang, HM Kocher… - Cells, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate
of less than 8%, and is predicted to become the second leading cause of cancer-related …
of less than 8%, and is predicted to become the second leading cause of cancer-related …